Featured Research

from universities, journals, and other organizations

Better Surveillance And More Awareness Needed To Deal With Rise In Antibiotic Resistance

Date:
May 20, 1998
Source:
National Academy Of Sciences
Summary:
As early as 1945, scientists discovered a pathogen that had developed resistance to penicillin. Since that time, antibiotic resistance has risen dramatically, posing a threat to public health, increasing medical costs, and fueling a resurgence in pathogens that were considered under control.

As early as 1945, scientists discovered a pathogen that had developed resistance to penicillin. Since that time, antibiotic resistance has risen dramatically, posing a threat to public health, increasing medical costs, and fueling a resurgence in pathogens that were considered under control.

Related Articles


Fighting the problem of antibiotic resistance will require a better, more coordinated system of surveillance, as well as an increased effort to prolong the effectiveness of existing antibiotics and to develop new drugs, says a new report from the Institute of Medicine's (IOM) Forum on Emerging Infections. The report summarizes the findings and opinions of participants at a recent workshop, and outlines options that policy-makers, pharmaceutical industry leaders, health officials, clinicians, researchers, and others may consider to combat this problem.

Though health officials have long argued the need for better surveillance, no country has developed a reliable, comprehensive system for tracking drug resistance, the report says. Efforts to understand its full impact are stifled by uncoordinated efforts to track across local, national, and international jurisdictions, as well as a lack of common standards among laboratories and health organizations for collecting data. An effective national surveillance program should allow broad access to information and data gathered from all parties, integrate information from participating laboratories into a national database, and distinguish cases of drug resistance occurring in hospitals from those found in the local community. On an international scale, policy-makers need to evaluate whether it is desirable to give more authority to the United Nations' World Health Organization or to the U.S. Centers for Disease Control and Prevention to lead a global surveillance effort.

Widespread, inappropriate use of antibiotics has led to premature emergence of resistance. Increasing the life of antibiotics will require changes in attitude and behavior among health care providers, patients, parents, managed-care organizations, the pharmaceutical industry, and others. Since no adequate enforcement mechanisms exist to ensure proper antibiotic use, current efforts consist primarily of trying to educate people about the hazards of antimicrobial overuse or misuse. Professional societies should collaborate to develop uniform guidelines that encourage better practices, the report says.

More research is needed to examine the impact of antibiotic overuse and misuse on humans; on finding new ways to define a drug's effectiveness; and on the benefits and risks of reducing antimicrobial dose and duration of therapy. Research also is needed on the human health effects of widespread agricultural use of antibiotics. A separate study on the use of antibiotics in chicken, cattle, and other food animals and products, and their potential impact on human health, will be completed by the National Research Council later this year.

In addition to preserving the effectiveness of the current groups of antibiotics, incentives are needed to develop new drugs. Pharmaceutical industry representatives at the workshop felt that efforts need to be directed towards promoting and fostering joint ventures that meet the scientific, legal, and regulatory concerns of industry and academic institutions alike.

The IOM's Forum on Emerging Infections was created in response to a request from the Centers for Disease Control and Prevention and the National Institute of Allergy and Infectious Diseases. It brings together representatives from academia, industry, government, and professional and interest groups to examine and discuss scientific and policy issues related to emerging infections. The Institute of Medicine is a private, non-profit organization that provides health policy advice under a congressional charter granted to the National Academy of Sciences.

This project is funded by Abbott Laboratories; the American Society for Microbiology; Applied Microbiology Inc.; Bristol Myers Squibb; the Burroughs Wellcome Fund; the Centers for Disease Control and Prevention; Eli Lilly & Co.; F. Hoffmann-La Roche; the Food and Drug Administration; Glaxo Wellcome; Merck and Co. Inc.; the National Institute of Allergy and Infectious Diseases; Pfizer Inc.; SmithKline Beecham Corp.; the U.S. Department of State; the U.S. Department of Veterans Affairs; and Wyeth-Ayerst.

Copies of Antimicrobial Resistance: Issues and Options are available from the National Academy Press for $25.00 (prepaid) plus shipping charges of $4.00 for the first copy and $.50 for each additional copy; tel. (202) 334-3313 or 1-800-624-6242. Reporters may obtain a copy from the Office of News and Public Information (contacts listed above).


Story Source:

The above story is based on materials provided by National Academy Of Sciences. Note: Materials may be edited for content and length.


Cite This Page:

National Academy Of Sciences. "Better Surveillance And More Awareness Needed To Deal With Rise In Antibiotic Resistance." ScienceDaily. ScienceDaily, 20 May 1998. <www.sciencedaily.com/releases/1998/05/980520081715.htm>.
National Academy Of Sciences. (1998, May 20). Better Surveillance And More Awareness Needed To Deal With Rise In Antibiotic Resistance. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/1998/05/980520081715.htm
National Academy Of Sciences. "Better Surveillance And More Awareness Needed To Deal With Rise In Antibiotic Resistance." ScienceDaily. www.sciencedaily.com/releases/1998/05/980520081715.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins